Injectable agents in the treatment of stress urinary incontinence in women: Where are we now?

Urology

Volumn 56, Issue 6 SUPPL. 1, 2000, Pages 32-40

  Dmochowski, Roger R ^a,c   Appell, Rodney A ^b  

^a North Texas Center for Urinary Control   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BULKING AGENT; CALCIUM ALGINATE; COAPTITE; COLLAGEN; COLLAGEN IMPLANT; DEFLUX; DEXTRANOMER; DIMETICONE; DURASPHERE; ENDOMATRIX; ETHYLENE VINYL ALCOHOL COPOLYMER; GLUTARALDEHYDE CROSS LINKED COLLAGEN; HYALURONIC ACID; HYDROXYAPATITE; HYLAGEL; LUBRICATING AGENT; POLITEF; POVIDONE; SCLEROSING AGENT; SILICONE; UNCLASSIFIED DRUG; URETHRIN; UROLASTIN; UROVIVE; URYX;

ARTIFICIAL EMBOLISM; BALLOON; FEMALE; HUMAN; IMPLANTATION; PATIENT SATISFACTION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; STRESS INCONTINENCE; VESICOURETERAL REFLUX;

EID: 0033645649     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)01019-0     Document Type: Review

References (82)

1. The injection treatment of stress incontinence
2. Deux incontinences apres adenomectomie gueries par injection de paraffine dans le perinee
3. Treatment of urinary incontinence with sclerosing solutions; indications, results, complications
4. Periurethral Teflon injection in urinary incontinence
5. Migration and granulomatous reaction after periurethral injection of Polytef (Teflon)
6. Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence
7. Periurethral collagen injections for genuine stress incontinence; a 2 year follow up
8. Transurethral collagen therapy in women
9. Para-urethral collagen implantation for female stress incontinence
10. Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence
11. Transurethral polytetrafluoroethylene injection in female patients with urinary incontinence
12. Injection therapy for stress incontinence
13. Periurethral polytetrafluoroethylene injection for urinary incontinence
14. Periurethral Teflon injection; a simple treatment for urinary incontinence
15. Endoscopic injection of Teflon for female urinary incontinence
16. Teflon injection in stress incontinence
17. Female urinary stress incontinence treated with Teflon injection
18. Periurethral polytetrafluoroethylene injection following urethral reconstruction in female patients with urinary incontinence
19. Teflon injection in female stress urinary incontinence; effect on urethral pressure profile and flow rate
20. Disappointing effect of endoscopic Teflon injection for female stress incontinence
21. Long-term follow up of women treated with periurethral Teflon injections for stress incontinence
22. Periurethral Teflon for female stress urinary incontinence; mid-term results
23. Chondrosarcoma of the larnyx
24. Histologic response to intradermal Zyderm and Zyplast (glutaraldehyde cross-linked) collagen in humans
25. Endoluminal ultrasonographic and histologic evaluation of periurethral collagen injection
26. Magnetic resonance imaging after intraurethral collagen injection injected for stress urinary incontinence
27. Implantation techniques for injectable collagen; two and one-half years of personal clinical experience
28. The use of periurethral injectables in the treatment of genuine stress incontinence
29. Injectables for urethral incompetence
30. Para-urethral collagen implantation for female stress incontinence
31. Early experience with intraurethral collagen injections for urinary incontinence
32. Injectable collagen for type 3 female stress urinary incontinence; the first 50 Australian patients
33. Periurethral injection of collagen in the treatment of intrinsic sphincter deficiency in the female patient
34. Periurethral collagen injections for genuine stress incontinence; a 2 year follow up
35. Periurethral implantation of glutaraldehyde cross-linked collagen (Contigen(®)) in women with type I or III stress incontinence; quantitative outcome measures
36. Collagen injections for treatment of urinary incontinence secondary to intrinsic sphincter deficiency
37. Endoscopic injection of glutaraldehyde cross-linked collagen for the treatment of intrinsic sphincter deficiency in women
38. Injection of glutaraldehyde cross-linked collagen for urinary incontinence; two-year efficacy by self-assessment
39. Collagen injection therapy for female intrinsic sphincter deficiency
40. GAX collagen in the treatment of urinary incontinence in elderly women; a two year follow up
41. Collagen for female stress urinary incontinence after a minimum 2-year follow-up
42. Periurethral collagen injection for the treatment of female stress urinary incontinence; 4 year follow-up results
43. The neglected free 'fat graft,' its behavior and clinical use
44. Technique for liposuction fat implementation and long term volume evaluation by magnetic resonance imaging
45. Transplantation of purified fat; a 3-year follow-up is disappointing
46. Technique for liposuction for reimplantation and long term volume evaluation by magnetic resonance imaging
47. Endoscopic autotransplantation of fat tissue in the treatment of urinary incontinence in the female
48. Surgical treatment of intrinsic urethral dsyfunction; injectables (fat)
49. Periurethral injection of autologous fat for the treatment of sphincteric incontinence
50. Periurethral fat injection in the treatment of recurrent genuine stress incontinence
51. Adipose tissue and lipid drop embolism following periurethral injection of autologus fat; case report and review of the literature
52. Endoscopic treatment of vesicoureteral reflux with a self-detachable balloon system
53. Detachable self-sealing membrane system for the endoscopic treatment of incontinence
54. Implantable microballoons; an attractive alternative in the management of intrinsic sphincter deficiency
55. Autologen; autologous, injectable dermal collagen
56. Autologous collagen vocal fold injection; a preliminary clinical study
57. The biological behavior of autologous collagen injected into the rabbit bladder
58. Endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes; preliminary results
59. Endoscopic treatment of vesicoureteal reflux with a chondrocyte-alginate suspension
60. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation
61. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux
62. Bonding of soft tissue to bioglass
63. Injectable bioglass as a potential substitute for injectable polytetrafluorethylene
64. Viscosupplementation with Hylan G-F 20; a 26 week controlled trial of efficacy and safety in the osteoarthritic knee
65. DiHA Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women
66. A new dextranomer based implant; morphological and DNA studies after injection in the pig bladder
67. 125idoine labeled dextranomer based implant into the rabbit bladder
68. A multicentre evaluation of a new surgical technique for urethral bulking in the treatment of genuine stress urinary incontinence
69. Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence
70. A single transurethral Macroplastique injection as primary treatment for stress incontinence in women
71. Endoscopic correction of intractable stress incontinence with silicone micro-implants
72. Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency
73. Periurethral injection therapy for the treatment of urinary incontinence
74. Use of a new mixture for embolization of intracranial vascular malformations; preliminary experimental experience